Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NIH-funded research links alterations to inflammatory protein, underscores vaccine importance.
Dr. Marrazzo is a renowned HIV and STI expert at the University of Alabama Birmingham.
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
The small study found no evidence of delayed development of antibodies in participants who experienced rebound after taking Paxlovid.
Higher levels of viral antigens in the blood correlated with more severe disease.
Fauci led the U.S. HIV research effort for nearly 40 years before becoming the nation’s leading COVID-19 medical advisor.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.